Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05098210
Title Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

malignant conjunctival melanoma

mucosal melanoma

Her2-receptor negative breast cancer

acral lentiginous melanoma

skin melanoma

Therapies

NeoVax + Nivolumab + Poly ICLC

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.